Lütje Susanne, Blex Sebastian, Gomez Benedikt, Schaarschmidt Benedikt M, Umutlu Lale, Forsting Michael, Jentzen Walter, Bockisch Andreas, Poeppel Thorsten D, Wetter Axel
Clinic for Nuclear Medicine, University Hospital Essen, Hufelandstraße 55, 45122 Essen, Germany.
Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Hufelandstraße 55, 45122 Essen, Germany.
PLoS One. 2016 Oct 18;11(10):e0164392. doi: 10.1371/journal.pone.0164392. eCollection 2016.
The aim of this optimization study was to minimize the acquisition time of 68Ga-HBED-CC-PSMA positron emission tomography/magnetic resonance imaging (PET/MRI) in patients with local and metastatic prostate cancer (PCa) to obtain a sufficient image quality and quantification accuracy without any appreciable loss.
Twenty patients with PCa were administered intravenously with the 68Ga-HBED-CC-PSMA ligand (mean activity 99 MBq/patient, range 76-148 MBq) and subsequently underwent PET/MRI at, on average, 168 min (range 77-320 min) after injection. PET and MR imaging data were acquired simultaneously. PET acquisition was performed in list mode and PET images were reconstructed at different time intervals (1, 2, 4, 6, 8, and 10 min). Data were analyzed regarding radiotracer uptake in tumors and muscle tissue and PET image quality. Tumor uptake was quantified in terms of the maximum and mean standardized uptake value (SUVmax, SUVmean) within a spherical volume of interest (VOI). Reference VOIs were drawn in the gluteus maximus muscle on the right side. PET image quality was evaluated by experienced nuclear physicians/radiologists using a five-point ordinal scale from 5-1 (excellent-insufficient).
Lesion detectability linearly increased with increasing acquisition times, reaching its maximum at PET acquisition times of 4 min. At this image acquisition time, tumor lesions in 19/20 (95%) patients were detected. PET image quality showed a positive correlation with increasing acquisition time, reaching a plateau at 4-6 min image acquisition. Both SUVmax and SUVmean correlated inversely with acquisition time and reached a plateau at acquisition times after 4 min.
In the applied image acquisition settings, the optimal acquisition time of 68Ga-PSMA-ligand PET/MRI in patients with local and metastatic PCa was identified to be 4 min per bed position. At this acquisition time, PET image quality and lesion detectability reach a maximum while SUVmax and SUVmean do not change significantly beyond this time point.
本优化研究的目的是将68Ga-HBED-CC-PSMA正电子发射断层扫描/磁共振成像(PET/MRI)在局部和转移性前列腺癌(PCa)患者中的采集时间降至最低,以获得足够的图像质量和定量准确性,且无明显损失。
20例PCa患者静脉注射68Ga-HBED-CC-PSMA配体(平均活度99 MBq/患者,范围76 - 148 MBq),随后在注射后平均168分钟(范围77 - 320分钟)接受PET/MRI检查。PET和MR成像数据同时采集。PET采集以列表模式进行,PET图像在不同时间间隔(1、2、4、6、8和10分钟)重建。分析肿瘤和肌肉组织中放射性示踪剂摄取以及PET图像质量的数据。肿瘤摄取通过球形感兴趣体积(VOI)内的最大和平均标准化摄取值(SUVmax、SUVmean)进行量化。在右侧臀大肌绘制参考VOI。经验丰富的核医学医师/放射科医生使用从5到1的五点有序量表(优秀 - 不足)评估PET图像质量。
病变可检测性随采集时间增加呈线性增加,在PET采集时间为4分钟时达到最大值。在此图像采集时间,19/20(95%)患者的肿瘤病变被检测到。PET图像质量与采集时间增加呈正相关,在4 - 6分钟图像采集时达到平稳状态。SUVmax和SUVmean均与采集时间呈负相关,并在4分钟后的采集时间达到平稳状态。
在所应用的图像采集设置中,局部和转移性PCa患者68Ga-PSMA配体PET/MRI的最佳采集时间确定为每个床位4分钟。在此采集时间,PET图像质量和病变可检测性达到最大值,而SUVmax和SUVmean在此时间点之后无明显变化。